Mirtazapine Tablets IP

Brand: Scythian Healthcare
Category: Neuro / Psychiatric Range
Packing: 10×10 Tablets

Mirtozin (Mirtazapine Tablets IP) is an effective antidepressant formulated for the management of Major Depressive Disorder (MDD) and associated symptoms such as anxiety, insomnia, and appetite loss. Known for its dual action on neurotransmitters, Mirtazapine helps improve mood, enhance sleep quality, and promote overall emotional balance.

Mirtozin is widely prescribed in psychiatric and general practice settings due to its fast onset of action, better sleep-inducing properties, and reduced risk of sexual side effects compared to other antidepressants.

Key Features
  • Supports treatment of Major Depressive Disorder (MDD)

  • Helps improve sleep quality and reduce nighttime awakenings

  • Beneficial for anxiety symptoms

  • Stimulates appetite and weight gain in patients with poor nutritional intake

  • Faster onset compared to many SSRIs

  • Suitable for long-term therapy under medical supervision

Composition

Mirtazapine Tablets IP
(Strength as per the product variant)

Uses / Indications

Mirtozin is clinically used for:

  • Major Depressive Disorder

  • Anxiety-related symptoms

  • Sleep disturbances

  • Appetite improvement in patients with depression

Why Choose Mirtozin?
  • Manufactured under strict quality standards

  • High patient compliance

  • Consistent therapeutic effect

  • Offered by Scythian Healthcare, a trusted name in neuro & psychiatric formulations

Mirtozin (Mirtazapine Tablets IP) by Scythian Healthcare is a clinically trusted antidepressant used for Major Depressive Disorder (MDD), insomnia, anxiety symptoms, and appetite loss. It is known for its faster onset of action and ability to improve sleep quality, making it a preferred choice in psychiatric and general medical practice.

🔹 Composition: Mirtazapine Tablets IP
🔹 Strength: As per pack
🔹 Indications: Depression, anxiety, sleep disturbances, appetite improvement

PCD Pharma Franchise Enquiry:
https://yourwebsite.com/pcd-pharma-franchise

Mayo Clinic – Mirtazapine Reference:
https://www.mayoclinic.org/drugs-supplements/mirtazapine-oral-route/description/drg-20067334

Category: